Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.

Slides:



Advertisements
Similar presentations
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Advertisements

Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer Min Ni, Yiwen Chen, Elgene Lim, Hallie Wimberly, Shannon T. Bailey, Yuuki Imai,
Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib Ling Li, Lisheng Wang, Liang Li, Zhiqiang.
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
New Views into the Prostate Cancer Genome
Chapter 08 The T Cell Receptor: Proteins and Genes
The Kinase-Independent, Second Life of CDK6 in Transcription
Volume 7, Issue 3, Pages (March 2005)
Charles Swanton, Julian Downward  Cancer Cell 
“Atypical” Regulation of Hedgehog-Dependent Cancers
Volume 19, Issue 5, Pages (May 2011)
RNA Identity Crisis: Hepatitis B Walks the LINE
NF-κB: A Coordinator for Epigenetic Regulation by MLL
Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension
Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma
IRS-1: Auditing the effectiveness of mTOR inhibitors
PI3K Regulatory Subunits Lose Control in Cancer
HSF1 in Translation Cancer Cell
The Ids Have It Cancer Cell
Mutant p53 gain of function: The NF-Y connection
Approaching TERRA Firma: Genomic Functions of Telomeric Noncoding RNA
The 3D Genome Shapes Up For Pluripotency
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
Killing Tumors by Keeping Ras and PI3′ Kinase Apart
A Sweet New Role for EGFR in Cancer
When Deletions Gain Functions: Commandeering Epigenetic Mechanisms
Agonizing Integrin Antagonists?
Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma
From Prescription to Transcription: Genome Sequence as Drug Target
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
Volume 26, Issue 1, Pages 1-2 (July 2014)
T.S. Karin Eisinger-Mathason, M. Celeste Simon  Cancer Cell 
Suppressing NFAT Increases VEGF Signaling in Hemangiomas
The Wind God Promotes Lung Cancer
Regulating Cancer Stem Cells the miR Way
Methed-Up FOXOs Can't In-Akt-ivate
Unraveling the Pros and Cons of Interferon-γ Gene Regulation
PU.1 Takes Control of the Dendritic Cell Lineage
CHD7 in Charge of Neurogenesis
Eukaryotic Transcription Activation: Right on Target
IRS-1: Auditing the effectiveness of mTOR inhibitors
Development of Androgen Receptor Antagonists with Promising Activity in Castration- Resistant Prostate Cancer  Howard C. Shen, Steven P. Balk  Cancer Cell 
Silencing Insulin Resistance through SIRT1
Proteins Kinases: Chromatin-Associated Enzymes?
Easy Stress Relief by EZH2
Proteins in Plant Brassinosteroid Signaling
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
William G. Nelson, Michael C. Haffner, Srinivasan Yegnasubramanian 
Volume 14, Issue 4, Pages (October 2008)
Nat. Rev. Urol. doi: /nrurol
Slugging It out: Fine Tuning the p53-PUMA Death Connection
Genome-Wide SNP Analysis in Cancer: Leukemia Shows the Way
Sticking It to Cancer with Molecular Glue for SHP2
To Infinium, and Beyond! Cancer Cell
Volume 22, Issue 4, Pages (April 2018)
All Roads Lead to the Ribosome
Taking LSD1 to a New High Cell
The TRIP from ULF to ARF Cancer Cell
There's a Time and a Place for MYCN
Gankyrin: An intriguing name for a novel regulator of p53 and RB
Ibrutinib Treatment of CLL: The Cancer Fights Back
Volume 12, Issue 6, Pages (December 2007)
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
Marking Emerging β- and γδ-Selected T Cells
Turning Reciprocal Feedback Regulation into Combination Therapy
Tackling Resistance to PI3K Inhibition by Targeting the Epigenome
Presentation transcript:

Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume 17, Issue 5, Pages 415-416 (May 2010) DOI: 10.1016/j.ccr.2010.04.022 Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 1 Coordinate Regulation of Target Genes by Androgen Receptor and ERG AR binding at enhancers of AR target gene causes looping and gene activation. The “GGAA” ETS motif is highly enriched at AR binding sites, raising the possibility that an unidentified ETS protein (not ERG) may coordinately regulate transcription in normal prostate cells (top). In ERG-positive prostate cancer, ERG now localizes at these sites, perhaps displacing an “endogenous” ETS factor, as well as gene promoters, and inhibits AR mediates transcriptional activation. Cancer Cell 2010 17, 415-416DOI: (10.1016/j.ccr.2010.04.022) Copyright © 2010 Elsevier Inc. Terms and Conditions